§ 40:1007 — Access to prescription monitoring information and audit trail information

Louisiana § 40:1007

• Jurisdiction: Louisiana
• Title 40: Public Health and Safety

Text

§1007. Access to prescription monitoring information and audit trail information
A. Except as provided in Subsections C, D, E, F, G, H, and I of this Section,
prescription monitoring information submitted to the board and audit trail information shall
be protected health information, not subject to public or open records law, including but not
limited to R.S. 44:1 et seq., and not subject to disclosure. Prescription monitoring
information and audit trail information shall not be available for civil subpoena from the
board nor shall such information be disclosed, discoverable, or compelled to be produced in
any civil proceeding nor shall such records be deemed admissible as evidence in any civil
proceeding for any reason. Notwithstanding this provision, law enforcement and
professional licensing, certification, or regulatory agencies may utilize prescription
monitoring information and audit trail information in the course of any investigation and
subsequent criminal and administrative proceedings, but only in accordance with federal and
state law and the requirements of this Part.
B. The board shall maintain procedures to ensure that the privacy and confidentiality
of patients and patient information collected, recorded, transmitted, and maintained, as well
as audit trail information, is not disclosed to persons or entities except as authorized or
required in Subsections C through J of this Section.
C. The board shall review the prescription monitoring information. If there is
reasonable suspicion to believe a breach of professional or occupational standards may have
occurred, the board shall notify the appropriate professional licensing agency with
jurisdiction over prescribers or dispensers and shall provide prescription monitoring
information required for an investigation.
D. The board shall provide prescription monitoring information to public or private
entities, whether located in or outside of the state, for public research, policy, or educational
purposes, but only after removing information that identifies or could be reasonably used to
identify prescribers, dispensers, and individual patients or persons who received prescriptions
from prescribers.
E. The following persons may access prescription monitoring information at no cost
and in the same or similar manner, and for the same or similar purposes, as those persons are
authorized to access similar protected health information under federal and state law and
regulation:
(1) Persons authorized to prescribe or dispense controlled substances or drugs of
concern, or their delegates as defined by rule, for the purpose of providing medical or
pharmaceutical care for their patients, or for verifying their prescribing records.
(2) Designated representatives from the professional licensing, certification, or
regulatory agencies of this state or another state charged with administrative oversight of
those professionals engaged in the prescribing or dispensing of controlled substances or other
drugs of concern.
(3) Designated representatives from the Louisiana Medicaid program regarding
Medicaid program recipients.
(4) Designated representatives of the board and any vendor or contractor establishing
or maintaining the prescription monitoring program.
(5) A medical examiner or coroner, or a delegate thereof, for the purpose of
investigating an individual's death.
(6) A licensed substance abuse addiction counselor providing services as part of a
state-licensed substance abuse or addiction treatment program.
(7) A probation or parole officer for the purpose of monitoring an offender's
compliance with participation in a drug diversion program or with other conditions of
probation or parole related to monitored drugs.
(8) An epidemiologist with the Louisiana Department of Health for the purpose of
assisting the board in analyzing prescription monitoring information in order to conduct
public health evaluations to support public policy and education pursuant to an agreement
with the board.
F. The board may provide a report containing prescription monitoring information
upon application of local, state, out-of-state, and federal law enforcement or prosecutorial
officials, including judicially supervised specialty courts within the criminal justice system
that are authorized by the Louisiana Supreme Court, engaged in the administration,
investigation, or enforcement of the laws governing controlled substances or other drugs of
concern in compliance with and as limited by the relevant requirements of any of the
following:
(1) A court order or court-ordered warrant, or a subpoena or summons issued by a
judicial officer.
(2) A grand jury subpoena.
(3) An administrative request, including an administrative subpoena or summons,
a civil or an authorized investigative demand, or similar process authorized under law,
provided by law enforcement to the board, and further, provided all of the following:
(a) The information sought is relevant and material to a legitimate law enforcement
inquiry.
(b) The request is specific and limited in scope to the extent reasonably practicable
in light of the purpose for which the information is sought.
(c) De-identified information, or limited information that does not identify or could
not reasonably lead to the identification of an individual patient, could not reasonably be
used.
G. The board may provide prescription monitoring information in response to queries
from prescription monitoring programs, electronic health information systems, and pharmacy
information systems located in other states, territories, federal districts, and federal
jurisdictions, through its participation in a secure interstate data exchange system. The
prescription monitoring information made available pursuant to this Subsection may be used
only in a manner consistent with this Section.
H. The board may provide prescription monitoring information to authorized users
of the prescription monitoring program via a state health information exchange or other third
party conduit that has been approved by the board.
I. The board may provide prescription monitoring information to any of the
following persons in accordance with procedures established by board regulation:
(1) An individual who requests his personal prescription monitoring information.
(2) A parent, legal guardian, or legal healthcare agent, for the purpose of reviewing
the history of monitored drugs dispensed to a child or an individual for whom the agent
makes healthcare decisions, to the extent consistent with federal and state confidentiality
laws and regulations.
(3) An executor of a will, or a court-appointed succession representative of an estate,
for the purpose of reviewing the history of monitored drugs dispensed to a deceased
individual.
J. The board may disclose audit trail information to individuals identified in
Paragraph (E)(2) and Subsections F and I of this Section for use in an active investigation
of an individual who submitted requests for prescription monitoring information.
K.(1) The board and advisory council shall not be subject to civil liability,
administrative action, or other legal or equitable relief for any of the following:
(a) Failure to possess prescription monitoring information that was not reported to
the board.
(b) Release of prescription monitoring information or audit trail information that was
factually incorrect.
(c) Release of prescription monitoring information or audit trail information to the
wrong person or entity.
(d) Unlawful access to prescription monitoring information by an individual, or
unlawful disclosure or use of prescription monitoring information by an individual who
requested and received prescription monitoring information pursuant to this Section.
(2) A dispenser or reporting agent shall not be subject to civil liability, administrative
action, or other legal or equitable relief for reporting prescription monitoring information to
the board.
(3) A prescriber, dispenser, or other individual, agency, or entity in proper possession
of prescription monitoring information or audit trail information pursuant to this Part shall
not be subject to civil liability, administrative action, or other legal or equitable relief for
accessing, using, or disclosing prescription monitoring information or audit trail information
pursuant to the provisions of this Section.

Legislative History

Acts 2006, No. 676, §1, eff. July 1, 2006; Acts 2010, No. 488, §1, eff. June 22, 2010; Acts 2012, No. 352, §1; Acts 2013, No. 110, §1; Acts 2015, No. 22, §1; Acts 2017, No. 241, §1, eff. June 14, 2017; Acts 2018, No. 206, §4; Acts 2018, No. 232, §1; Acts 2019, No. 80, §1.